Cargando…

Expanded newborn screening for inherited metabolic disorders by tandem mass spectrometry in a northern Chinese population

Tandem mass spectrometry (MS/MS) has been developed as one of the most important diagnostic platforms for the early detection and screening of inherited metabolic disorders (IMDs). To determine the disease spectrum and genetic characteristics of IMDs in Suqian city of Jiangsu province in the norther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hong, Wang, Yanyun, Qiu, Yali, Zhang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562093/ https://www.ncbi.nlm.nih.gov/pubmed/36246604 http://dx.doi.org/10.3389/fgene.2022.801447

Ejemplares similares

Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population
por: Wang, Ting, et al.
Publicado: (2019)

Application of Next-Generation Sequencing Following Tandem Mass Spectrometry to Expand Newborn Screening for Inborn Errors of Metabolism: A Multicenter Study
por: Yang, Yuqi, et al.
Publicado: (2019)

Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population
por: Li, Xia, et al.
Publicado: (2022)

An Easily Overlooked Contamination of Syringes in Newborn Screening by Tandem Mass Spectrometry
por: Wang, Yanyun, et al.
Publicado: (2021)

Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in newborns from Xinxiang city in China
por: Ma, Shujun, et al.
Publicado: (2020)

Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry
por: Padilla, Carmencita D., et al.
Publicado: (2022)

Tandem Mass Spectrometry Screening for Inborn Errors of Metabolism in Newborns and High-Risk Infants in Southern China: Disease Spectrum and Genetic Characteristics in a Chinese Population
por: Tan, Jianqiang, et al.
Publicado: (2021)

Expanded Newborn Screening Using Tandem Mass Spectrometry: Seven Years of Experience in Eastern Sicily
por: Messina, MariaAnna, et al.
Publicado: (2018)

Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience
por: Ruoppolo, Margherita, et al.
Publicado: (2022)

Non-derivatizing Tandem Mass Spectrometry Assay for Expanded Newborn Screening and Cutoffs for Preterm Neonates
por: Lee, Joon Hee, et al.
Publicado: (2023)

Expanded Newborn Screening for Inborn Errors of Metabolism and Genetic Characteristics in a Chinese Population
por: Guo, Kejian, et al.
Publicado: (2018)

Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan
por: Shigematsu, Yosuke, et al.
Publicado: (2021)

Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs
por: Gelb, Michael H., et al.
Publicado: (2017)

Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
por: Gelb, Michael H., et al.
Publicado: (2022)

Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry
por: Lin, Yiming, et al.
Publicado: (2019)

Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate
por: Cohen, Arieh S., et al.
Publicado: (2019)

The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening
por: Ling, Shiying, et al.
Publicado: (2022)

Postanalytical tools improve performance of newborn screening by tandem mass spectrometry
por: Hall, Patricia L., et al.
Publicado: (2014)

Expanded Newborn Screening Program in Slovenia using Tandem Mass Spectrometry and Confirmatory Next Generation Sequencing Genetic Testing
por: Lampret, Barbka Repič, et al.
Publicado: (2020)

Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
por: Yoon, Hye-Ran
Publicado: (2015)

Newborn Sickle Cell Disease Screening Using Electrospray Tandem Mass Spectrometry
por: Daniel, Yvonne, et al.
Publicado: (2018)

Erratum to: Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
por: Yoon, Hye-Ran
Publicado: (2015)

Reference Standards for Newborn Screening of Metabolic Disorders by Tandem Mass Spectrometry: A Nationwide Study on Millions of Chinese Neonatal Populations
por: He, Falin, et al.
Publicado: (2021)

Identification of a frit-related sample carryover in newborn screening by tandem mass spectrometry
por: Kim, Kyunghun, et al.
Publicado: (2023)

Identification of Non-Canonical Translation Products in C. elegans Using Tandem Mass Spectrometry
por: Parmar, Bhavesh S., et al.
Publicado: (2021)

Improved Reagents for Newborn Screening of Mucopolysaccharidosis Types I, II, and VI by Tandem Mass Spectrometry
por: Chennamaneni, Naveen Kumar, et al.
Publicado: (2014)

Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry()
por: Elliott, Susan, et al.
Publicado: (2016)

Response to Gelb et al.: “Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs”
por: Millington, David S.
Publicado: (2017)

Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening
por: Cicalini, Ilaria, et al.
Publicado: (2021)

Establishment of Cutoff Values for Newborn Screening of Six Lysosomal Storage Disorders by Tandem Mass Spectrometry
por: Li, Ruotong, et al.
Publicado: (2022)

Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population
por: Han, Minje, et al.
Publicado: (2011)

Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis
por: Pfeil, Johannes, et al.
Publicado: (2013)

Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: By tandem mass spectrometry
por: Elliott, Susan, et al.
Publicado: (2016)

A Case of Suspected Hyperphenylalaninemia at Newborn Screening by Tandem Mass Spectrometry during Total Parenteral Nutrition
por: Pieragostino, Damiana, et al.
Publicado: (2020)

Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening
por: Bower, Alexandra, et al.
Publicado: (2019)

Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology
por: Yu, Mingren, et al.
Publicado: (2022)

Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe
por: Jones, Simon A., et al.
Publicado: (2022)

Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia
por: Céspedes, Nora, et al.
Publicado: (2017)

Newborn Screen for X-Linked Adrenoleukodystrophy Using Flow Injection Tandem Mass Spectrometry in Negative Ion Mode
por: Teber, Tarek A., et al.
Publicado: (2022)

The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives
por: de Hora, Mark, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2eurk9tr2gk0gpj5vndmqprt5o